Jitao Zhou1 article listing Jitao Zhou in Nature Communications, indexed by Paperzzz from Crossref and OSF.Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study Nature Communications